Germany· DE-A57-ac74d50ec0142681
Ampres
A medicinal product containing chloroprocaine hydrochloride, registered in Germany by Sintetica Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Chloroprocaine Hydrochloride
- Manufacturer
- Sintetica Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chloroprocaine hydrochloride in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAmpres 10 mg/ml, soluzione iniettabileSintetica SA
- United States(CHLOROPROCAINE HCIHF Acquisition Co LLC, DBA HealthFirst
- BelgiumAmpres 10 mg/mlNordic Group
- SpainAMPRES 10 MG/ML SOLUCION INYECTABLEB Braun Medical S.A.
- FinlandAmpresB. Braun Melsungen AG
- United KingdomAmpres 400mg/20ml solution for injection vialsB.Braun Medical Ltd
- IrelandAmpres 10mg/ml solution for injectionB. Braun Melsungen AG
- SwedenAmpres 10 mg/ml Injektionsvätska, lösningB. Braun Melsungen AG
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Ampres, Visiclor
- Belgium · Ampres
- Bulgaria · Ампрес
- Denmark · Ampres
- Estonia · Clorotekal
- Spain · Ampres
- Finland · Ampres
- France · Clorotekal
- United Kingdom (Northern Ireland) · Ampres
- Greece · Ampres
- Croatia · Clorotekal
- Hungary · Clorotekal
- Italy · Decelex
- Luxembourg · Ampres
- Latvia · Clorotekal
- Netherlands · Ampres
- Norway · Ampres
- Poland · Ampres
- Portugal · Ampres
- Sweden · Ampres
- Slovenia · Decelex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32061fb8-2b17-466a-83f6-da23138b2c96 GET /v1/drugs/32061fb8-2b17-466a-83f6-da23138b2c96?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Perineural Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Chloroprocaine Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about chloroprocaine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.